Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

BACKGROUND: Assessing the cost-effectiveness of treatments in rheumatoid arthritis (RA) is of growing importance due to the chronic nature of the disease, rising treatment costs, and budget-constrained health care systems. This analysis assesses the cost-effectiveness of modified-release (MR) predni...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlop, William, Iqbal, Itrat, Khan, Ifty, Ouwens, Mario, Heron, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816994/
https://www.ncbi.nlm.nih.gov/pubmed/24204166
http://dx.doi.org/10.2147/CEOR.S47867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816994/
https://www.ncbi.nlm.nih.gov/pubmed/24204166
http://dx.doi.org/10.2147/CEOR.S47867

Ejemplares similares